Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
Services professionnels
Témoignages clients
Newsroom
Blog
Rapport mondial sur l'innovation
Glossaire
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
LLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport V2G, V2H, and V2X patent landscape 2026: converter topologies, grid protocols, market readiness, and strategic IP signals for bidirectional EV charging.
Article | Rapport Engineering tradeoffs between monolithic ceramic and ceramic matrix composite turbine shroud designs: material behaviour, cooling, damage tolerance, and IP landscape.
Article | Rapport Avalglucosidase alfa (Nexviazyme) vs cipaglucosidase/miglustat in late-onset Pompe disease: competitive landscape, ERT mechanisms, and next-generation strategies.
Article | Rapport Explore the 2026 landscape of high-performance polyimide materials for flexible displays and space applications — key technologies, players, and innovation trends.
Article | Rapport Static vs dynamic mechanical analysis for viscoelastic polymer characterization: key differences, test methods, and how to choose the right approach for your R&D.
Article | Rapport Povetacicept (ALPN-303) enters Phase II in myasthenia gravis as Vertex pursues IgAN BLA accelerated approval. Explore the dual BAFF/APRIL pipeline strategy.
Article | Rapport Lithium metal anodes offer 3,860 mAh g⁻¹ capacity—10× graphite. Explore the 2026 technology landscape: SEI engineering, 3D hosts, anode-free designs, and manufacturing readiness signals.
Article | Rapport How engineers validate electromagnetic compatibility of wireless medical devices under FCC Part 15 and IEC 60601-1-2: testing protocols, standards, and regulatory strategy.
Article | Rapport How does the niraparib + pembrolizumab PARP/IO combination work in HRD ovarian cancer? A deep dive into GSK's Phase III FIRST study patent landscape and clinical rationale.
Article | Rapport Mapping the 2026 SMR control system patent landscape: multi-module MCR architecture, AI-assisted management, FPGA protection systems, and load-following IP trends.
Article | Rapport Explore the 2026 drug-eluting coating materials landscape for cardiovascular and orthopedic implants: polymer platforms, release mechanisms, and competitive dynamics.
Article | Rapport What blocks swarm drone deployment in large-scale precision agriculture? Explore the key technical, computational, and regulatory barriers holding back autonomous farm management.
Article | Rapport Iron-air batteries offer ~10,000 Wh/L theoretical capacity at a fraction of lithium-ion cost. Explore the 2026 technology landscape, key patents, and emerging IP white spaces.
Article | Rapport DESTINY-Breast09 pits Enhertu (trastuzumab deruxtecan) against pertuzumab/trastuzumab in first-line HER2+ metastatic breast cancer. Explore the patent and clinical landscape.
Article | Rapport Explore the 2026 bone scaffold materials landscape: hydroxyapatite, bioglass, and 3D-printed composites in orthopedic and regenerative medicine innovation.